Skip To Main Content
Vassiliki Antari on Muck Rack

Vassiliki Antari

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile
Back to Vassiliki Antari’s profile

Articles by Vassiliki Antari

Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia

|
By Athanasios Tragiannidis, Vassiliki Antari, Eleni Tsotridou, Theodoros Sidiropoulos
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia

|
By Athanasios Tragiannidis, Eleni Tsotridou, Theodoros Sidiropoulos, Vassiliki Antari
| Preprints.org
Preprint Case Report Version 1 This version is not peer-reviewed Version 1 : Received: 31 July 2024 / Approved: 2 August 2024 / Online: 2 August 2024 (03:55:46 CEST) Tragiannidis, A.; Antari, V.; Tsotridou, E.; Sidiropoulos, T.; Kaisari, A.; Palabougiouki, M.; Vyzantiadis, T.-A.; Hatzipantelis, E.; Tsinopoulou, A.-G.; Goussetis, E. Complete Remission with Inotuzumab Ozogamicin as Fourth-Line Salvage Therapy in a Child with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Open in Who Shared Issue with article?
Show More